Dietary walnut suppression of colorectal cancer in mice: Mediation by miRNA patterns and fatty acid incorporation

Journal of Nutritional Biochemistry

Volumn 26, Issue 7, 2015, Pages 776-783

  Tsoukas, Michael A ^a,b   Ko, Byung Joon ^a   Witte, Theodore R ^c   Dincer, Fadime ^a   Elaine Hardman, W ^c   Mantzoros, Christos S ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; Anti inflammation; Apoptosis; Colon cancer; Fatty acids; MiRNA; Walnut

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; FATTY ACID; ICOSAPENTAENOIC ACID; LINOLENIC ACID; MICRORNA; OMEGA 3 FATTY ACID;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; COLON MUCOSA; COLORECTAL CANCER; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LIPID COMPOSITION; MOUSE; NONHUMAN; OMENTUM; TUMOR VOLUME; WALNUT; ANALYSIS; ANIMAL; CARCINOMA; CHEMISTRY; COLON; COLORECTAL NEOPLASMS; DRUG SCREENING; FUNCTIONAL FOOD; GENE EXPRESSION REGULATION; HT 29 CELL LINE; INTESTINE MUCOSA; INTRAABDOMINAL FAT; METABOLISM; NUDE MOUSE; NUT; PATHOLOGY; RANDOMIZATION;

ANIMALS; CARCINOMA; COLON; COLORECTAL NEOPLASMS; FATTY ACIDS, OMEGA-3; FEMALE; FUNCTIONAL FOOD; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HT29 CELLS; HUMANS; INTESTINAL MUCOSA; INTRA-ABDOMINAL FAT; JUGLANS; MICE, NUDE; MICRORNAS; NUTS; RANDOM ALLOCATION; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84942991978     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2015.02.009     Document Type: Article

References (71)

1. Wiseman M. The Second World Cancer Research Fund/American Institute for Cancer Research, Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Proc Nutr Soc 2008;67(3):253-6.
2. Chan AT, Giovannucci EL. Primary prevention of colorectal cancer. Gastroenterology 2010;138(6):2029-43.
3. Fung T, Hu FB, Fuchs C, et al. Major dietary patterns and the risk of colorectal cancer in women. Arch Intern Med 2003;163(3):309-14.
4. Platz EA, Willett WC, Colditz GA, et al. Proportion of colon cancer risk that might be preventable in a cohort of middle-aged us men. Cancer Causes Control 2000; 11(7):579-88.
5. Jenab M, Ferrari P, Slimani N, et al. Association of nut and seed intake with colorectal cancer risk in the european prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev 2004;13(10):1595-603.
6. Singh PN, Fraser GE. Dietary risk factors for colon cancer in a low-risk population. Am J Epidemiol 1998;148(8):761-74.
7. Yeh CC, You SL, Chen CJ, et al. Peanut consumption and reduced risk of colorectal cancer in women: a prospective study in taiwan. World J Gastroenterol 2006; 12(2):222-7.
8. Gonzalez CA, Salas-Salvado J. The potential of nuts in the prevention of cancer. Br J Nutr 2006;96(Suppl. 2):S87-94.
9. Petrik MB, McEntee MF, Johnson BT, et al. Highly unsaturated (n-3) fatty acids, but not alpha-linolenic, conjugated linoleic or gamma-linolenic acids, reduce tumorigenesis in apc(min/+) mice. J Nutr 2000;130(10):2434-43.
10. Berquin IM, Edwards IJ, Chen YQ. Multi-targeted therapy of cancer by omega-3 fatty acids. Cancer Lett 2008;269(2):363-77.
11. Han DH, Lee MJ, Kim JH. Antioxidant and apoptosis-inducing activities of ellagic acid. Anticancer Res 2006;26(5a):3601-6.
12. Liu D, Kim DH, Park JM, et al. Piceatannol inhibits phorbol ester-induced NF-kappa b activation and Cox-2 expression in cultured human mammary epithelial cells. Nutr Cancer 2009;61(6):855-63.
13. Nagel JM, Brinkoetter M, Magkos F, et al. Dietary walnuts inhibit colorectal cancer growth in mice by suppressing angiogenesis. Nutrition 2012;28(1):67-75.
14. Hardman WE, Ion G. Suppression of implanted mda-mb 231 human breast cancer growth in nude mice by dietary walnut. Nutr Cancer 2008;60(5):666-74.
15. Hardman WE, Ion G, Akinsete JA, et al. Dietary walnut suppressed mammary gland tumorigenesis in the c(3)1 tag mouse. Nutr Cancer 2011;63(6):960-70.
16. Carvalho M, Ferreira PJ, Mendes VS, et al. Human cancer cell antiproliferative and antioxidant activities of Juglans regia L. Food Chem Toxicol 2010;48(1):441-7.
17. Ion G, Akinsete JA, Hardman WE. Maternal consumption of canola oil suppressed mammary gland tumorigenesis in c3(1) tag mice offspring. BMC Cancer 2010;10: 81-93.
18. USA national nutrient database for standard reference, release 22. In: U.S. Department of Agriculture ARS, editor. USDA Nutrient Laboratory home page; 2009.
19. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116(2):281-97.
20. Shah MS, Schwartz SL, Zhao C, et al. Integrated microRNA and mRNA expression profiling in a rat colon carcinogenesis model: effect of a chemo-protective diet. Physiol Genomics 2011;43(10):640-54.
21. Mayr C, Bartel DP. Widespread shortening of 3'UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell 2009;138(4):673-84.
22. Aslam MI, Taylor K, Pringle JH, et al. MicroRNAs are novel biomarkers of colorectal cancer. Br J Surg 2009;96(7):702-10.
23. Slaby O, Svoboda M, Michalek J, et al. MicroRNAs in colorectal cancer: translation of molecular biology into clinical application. Mol Cancer 2009;8:102-15.
24. Asangani IA, Rasheed SA, Nikolova DA, et al. MicroRNA-21 (mir-21) posttranscriptionally downregulates tumor suppressor pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 2008;27(15):2128-36.
25. Zhu S, Wu H, Wu F, et al. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res 2008;18(3):350-9.
26. Sun M, Estrov Z, Ji Y, et al. Curcumin (diferuloylmethane) alters the expression profiles of micrornas in human pancreatic cancer cells. Mol Cancer Ther 2008; 7(3):464-73.
27. Kutay H, Bai S, Datta J, et al. Downregulation of mir-122 in the rodent and human hepatocellular carcinomas. J Cell Biochem 2006;99(3):671-8.
28. Wang Y, Lee AT, Ma JZ, et al. Profiling microrna expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target. J Biol Chem 2008;283(19):13205-15.
29. Jensen SK. Improved Bligh and Dyer extraction procedure. Lipid Technol 2008; 20(12):280-1.
30. http://www3.Appliedbiosystems.Com/cms/groups/mcb_marketing/documents/generaldocuments/cms_044972.Pdf; 2014.
31. He S, Su H, Liu C, et al. MicroRNA-encoding long non-coding RNAs. BMC Genomics 2008;9:236-47.
32. Newmark HL, Yang K, Lipkin M, et al. A Western-style diet induces benign and malignant neoplasms in the colon of normal c57bl/6 mice. Carcinogenesis 2001; 22(11):1871-5.
33. Dougherty U, Cerasi D, Taylor I, et al. Epidermal growth factor receptor is required for colonic tumor promotion by dietary fat in the azoxymethane/dextran sulfate sodium model: roles of transforming growth factor-{alpha} and ptgs2. Clin Cancer Res 2009;15(22):6780-9.
34. Zhu H, Dougherty U, Robinson V, et al. Egfr signals downregulate tumor suppressors mir-143 and mir-145 in Western diet-promoted murine colon cancer: role of g1 regulators. Mol Cancer Res 2011;9(7):960-75.
35. Ross SA, Davis CD. Microrna, nutrition, and cancer prevention. Adv Nutr 2011; 2(6):472-85.
36. Ng EK, Chong WW, Jin H, et al. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut 2009;58(10):1375-81.
37. Resnick KE, Alder H, Hagan JP, et al. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time pcr platform. Gynecol Oncol 2009;112(1):55-9.
38. Yu SL, Chen HY, Chang GC, et al. Microrna signature predicts survival and relapse in lung cancer. Cancer Cell 2008;13(1):48-57.
39. Schetter AJ, Leung SY, Sohn JJ, et al. Microrna expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 2008;299(4): 425-36.
40. Nugent M, Miller N, Kerin MJ. MicroRNAs in colorectal cancer: function, dysregulation and potential as novel biomarkers. Eur J Surg Oncol 2011;37(8):649-54.
41. Krichevsky AM, Gabriely G. Mir-21: a small multi-faceted RNA. J Cell Mol Med 2009;13(1):39-53.
42. Dews M, Homayouni A, Yu D, et al. Augmentation of tumor angiogenesis by a mycactivated microRNA cluster. Nat Genet 2006;38(9):1060-5.
43. Xu K, Chen Z, Qin C, et al. Mir-7 inhibits colorectal cancer cell proliferation and induces apoptosis by targeting xrcc2. Oncol Targets Ther 2014;7:325-32.
44. Michael MZ, O'Connor SM, van Holst Pellekaan NG, et al. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 2003;1(12):882-91.
45. Zhang GJ, Zhou H, Xiao HX, et al. Mir-378 is an independent prognostic factor and inhibits cell growth and invasion in colorectal cancer. BMC Cancer 2014;14(1):109-18.
46. Thornton AM, Shevach EM. Cd4 + cd25+ immunoregulatory t cells suppress polyclonal t cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998;188(2):287-96.
47. Strillacci A, Griffoni C, Sansone P, et al. Mir-101 downregulation is involved in cyclooxygenase-2 overexpression in human colon cancer cells. Exp Cell Res 2009; 315(8):1439-47.
48. Chang MS, McNinch J, Basu R, et al. Cloning and characterization of the human neutrophil-activating peptide (ena-78) gene. J Biol Chem 1994;269(41): 25277-82.
49. Foster JG, Blunt MD, Carter E, et al. Inhibition of pi3k signaling spurs new therapeutic opportunities in inflammatory/autoimmune diseases and hematological malignancies. Pharmacol Rev 2012;64(4):1027-54.
50. Yuan TL, Cantley LC. Pi3k pathway alterations in cancer: variations on a theme. Oncogene 2008;27(41):5497-510.
51. Liu P, Cheng H, Roberts TM, et al. Targeting the phosphoinositide 3-kinase pathway in cancer. Nat Rev Drug Discov 2009;8(8):627-44.
52. Davidson LA, Wang N, Shah MS, et al. N-3 polyunsaturated fatty acids modulate carcinogen-directed non-coding microRNA signatures in rat colon. Carcinogenesis 2009;30(12):2077-84.
53. Huang YC, Jessup JM, Forse RA, et al. N-3 fatty acids decrease colonic epithelial cell proliferation in high-risk bowel mucosa. Lipids 1996(31 Suppl.):S313-7.
54. Iigo M, Nakagawa T, Ishikawa C, et al. Inhibitory effects of docosahexaenoic acid on colon carcinoma 26 metastasis to the lung. Br J Cancer 1997;75(5):650-5.
55. Dodin S, Cunnane SC, Masse B, et al. Flaxseed on cardiovascular disease markers in healthy menopausal women: a randomized, double-blind, placebo-controlled trial. Nutrition 2008;24(1):23-30.
56. Zhao G, Etherton TD, Martin KR, et al. Dietary alpha-linolenic acid reduces inflammatory and lipid cardiovascular risk factors in hypercholesterolemic men and women. J Nutr 2004;134(11):2991-7.
57. Begin ME, Ells G, Horrobin DF. Polyunsaturated fatty acid-induced cytotoxicity against tumor cells and its relationship to lipid peroxidation. J Natl Cancer Inst 1988;80(3):188-94.
58. Kim JY, Park HD, Park E, et al. Growth-inhibitory and proapoptotic effects of alphalinolenic acid on estrogen-positive breast cancer cells. Ann N Y Acad Sci 2009; 1171:190-5.
59. Brinkman MT, Karagas MR, Zens MS, et al. Intake of alpha-linolenic acid and other fatty acids in relation to the risk of bladder cancer: results from the New Hampshire case-control study. Br J Nutr 2011;106(7):1070-7.
60. Hac-Wydro K. Studies on beta-sitosterol and ceramide-induced alterations in the properties of cholesterol/sphingomyelin/ganglioside monolayers. Biochim Biophys Acta 2013;1828(11):2460-9.
61. Vundru SS, Kale RK, Singh RP. Beta-sitosterol induces g1 arrest and causes depolarization of mitochondrial membrane potential in breast carcinoma mdamb-231 cells. BMC Complement Altern Med 2013;13:280-9.
62. Campbell SE, Musich PR, Whaley SG, et al. Gamma tocopherol upregulates the expression of 15-s-hete and induces growth arrest through a ppar gammadependent mechanism in pc-3 human prostate cancer cells. Nutr Cancer 2009; 61(5):649-62.
63. Kallio T, Kallio J, Jaakkola M, et al. Urolithins display both antioxidant and prooxidant activities depending on assay system and conditions. J Agric Food Chem 2013;61(45):10720-9.
64. Qiu Z, Zhou B, Jin L, et al. In vitro antioxidant and antiproliferative effects of ellagic acid and its colonic metabolite, urolithins, on human bladder cancer t24 cells. Food Chem Toxicol 2013;59:428-37.
65. Larrosa M, Gonzalez-Sarrias A, Garcia-Conesa MT, et al. Urolithins, ellagic acidderived metabolites produced by human colonic microflora, exhibit estrogenic and antiestrogenic activities. J Agric Food Chem 2006;54(5):1611-20.
66. Heneghan HM, Miller N, McAnena OJ, et al. Differential mirna expression in omental adipose tissue and in the circulation of obese patients identifies novel metabolic biomarkers. J Clin Endocrinol Metab 2011;96(5):E846-50.
67. Tang X, Muniappan L, Tang G, et al. Identification of glucose-regulated mirnas from pancreatic {beta} cells reveals a role for mir-30d in insulin transcription. RNA 2009;15(2):287-93.
68. Tang X, Tang G, Ozcan S. Role of microRNAs in diabetes. Biochim Biophys Acta 2008;1779(11):697-701.
69. Baroukh N, Ravier MA, Loder MK, et al. Microrna-124a regulates foxa2 expression and intracellular signaling in pancreatic beta-cell lines. J Biol Chem 2007;282(27): 19575-88.
70. Xie H, Lim B, Lodish HF. Micrornas induced during adipogenesis that accelerate fat cell development are downregulated in obesity. Diabetes 2009;58(5):1050-7.
71. Esau C, Davis S, Murray SF, et al. Mir-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 2006;3(2):87-98.